OmniAb, Inc. (OABI)
About OmniAb, Inc.
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $18.7M
- Net income
- -$64.8M
- Total assets
- $300.9M
- Market cap
- $294.3M
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $294.3M
- Shares outstanding
- 63.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 1, 2022
OmniAb, Inc. (OABI) Stock Price
- Reported a net loss of $64.8M in FY2025.
- Trading 8% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review OmniAb, Inc..
Write a review
News about OmniAb, Inc.
News & sentiment via Polygon.io
OmniAb, Inc.: frequently asked questions
Is OmniAb, Inc. an American company?
OmniAb, Inc. is a US-based company headquartered in Emeryville, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is OmniAb, Inc. headquartered?
OmniAb, Inc. is headquartered in Emeryville, California, United States.
Is OmniAb, Inc. publicly traded?
Yes — OmniAb, Inc. is a publicly traded company. Its stock trades under the ticker symbol OABI on the NASDAQ.
What does OmniAb, Inc. do?
OmniAb, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
